The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 28, 2010
Filed:
Dec. 05, 2006
Bailin Tu, Lake Bluff, IL (US);
Joan D. Tyner, Beach Park, IL (US);
James W. Scheffel, Shelby, NC (US);
Michael K. White, Framingham, MA (US);
Jeffrey M. Werneke, Grayslake, IL (US);
Robert N. Ziemann, Lindenhurst, IL (US);
David J. Hawksworth, Round Lake Beach, IL (US);
Mary S. Pinkus, Chicago, IL (US);
Robin A. Gutierrez, Gurnee, IL (US);
Bailin Tu, Lake Bluff, IL (US);
Joan D. Tyner, Beach Park, IL (US);
James W. Scheffel, Shelby, NC (US);
Michael K. White, Framingham, MA (US);
Jeffrey M. Werneke, Grayslake, IL (US);
Robert N. Ziemann, Lindenhurst, IL (US);
David J. Hawksworth, Round Lake Beach, IL (US);
Mary S. Pinkus, Chicago, IL (US);
Robin A. Gutierrez, Gurnee, IL (US);
Abbott Laboratories, Abbott Park, IL (US);
Abstract
Recombinant antibodies, including chimeric antibodies, specific for hepatitis C (HCV) antigenic proteins are provided. The recombinant antibodies specifically bind to diagnostically relevant regions of HCV proteins and are thus suitable for use, for example, as diagnostic reagents for the detection of HCV, and/or as standardization reagents or positive control reagents in assays for the detection of HCV. The recombinant antibodies can also be used in the treatment or prevention of a HCV infection.